康美药业(600518.SH)上半年净利润1690.14万元，同比增长7.24%

Group 1 - The company reported a revenue of 2.577 billion yuan for the first half of 2025, representing a year-on-year increase of 4.17% [1] - The net profit attributable to shareholders of the listed company was 16.9014 million yuan, showing a year-on-year growth of 7.24% [1] - The basic earnings per share were 0.001 yuan [1]